News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Executive Casts Doubt on Possibility of Alexion Pharmaceuticals Inc. (ALXN) Buyout



9/12/2013 7:37:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Treating ultra-rare diseases is a distinct business from Roche's (ROG.VX) current area of expertise, the Swiss group's head of pharmaceuticals said, in comments that may cast doubt on its interest in Alexion Pharmaceuticals (ALXN.O).

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Investors


comments powered by Disqus
Reuters
Investors
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES